Render Target: SSR
Render Timestamp: 2025-01-09T19:56:03.553Z
Commit: 199712eb9daea12d88cc0e67894a8a09f475f8cb
XML generation date: 2024-09-30 01:53:48.713
Product last modified at: 2025-01-01T09:06:49.499Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

Securin (D2B6O) Rabbit mAb #13445

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 25
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:200

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    Securin (D2B6O) Rabbit mAb recognizes endogenous levels of total securin protein. Based on western blot of overexpressed proteins, this antibody will also recognize securin 2 (PTTG2) to a lesser extent.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Val19 of human securin (PTTG1) protein.

    Background

    Securin is a regulatory protein that contributes to mitotic checkpoint control, p53 activity, DNA repair, and cell migration. The securin protein prevents premature separation of sister chromatids by inhibiting the protease separase, which cleaves the cohesin complex at the onset of anaphase to allow for sister chromatid segregation (1,2). In mouse oocytes, securin regulates cyclin B stability and G2/M transition (3). Securin negatively affects the transcriptional activity of p53, preventing p53-regulated apoptosis (4). Research studies indicate that securin plays a role in microtubule nucleation, cell polarization, and cell migration (5). Additional research indicates that securin expression may be useful as a biomarker for human breast cancer (6-8). The pituitary tumor-transforming gene 1 (PTTG1) encodes for securin protein, while the highly homologous securin 2 protein is transcribed from the related PTTG2 gene. Securin 2 (PTTG2) protein lacks the ability to inhibit separase activity and may function primarily in cell adhesion and migration (9,10).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    XP is a registered trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.